Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 118.38% | -29.16% | -56.82% | -50.83% | 8.97% |
| Total Receivables | -92.13% | -9.15% | -5.27% | -10.38% | -46.29% |
| Inventory | -32.86% | 0.91% | -18.10% | -19.88% | -- |
| Prepaid Expenses | -61.07% | -90.76% | 260.51% | 176.35% | -58.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -26.73% | 2.49% | 83.51% | 211.94% | 1,796.58% |
| Total Current Assets | -30.66% | -9.67% | 4.15% | -17.60% | -12.94% |
|
|
|||||
| Total Current Assets | -30.66% | -9.67% | 4.15% | -17.60% | -12.94% |
| Net Property, Plant & Equipment | -11.27% | -16.39% | 108.78% | -16.18% | -5.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.29% | -2.25% | -2.17% | -2.10% | -2.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -21.14% | -7.48% | 2.85% | -13.12% | -10.03% |
|
|
|||||
| Total Accounts Payable | -24.05% | 39.46% | 41.64% | -59.41% | 141.17% |
| Total Accrued Expenses | 48.85% | 11.86% | 27.57% | -6.45% | -43.46% |
| Short-term Debt | -34.16% | 1.58% | 78.74% | 75.75% | 105.99% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.05% | 81.47% | 66.72% | -6.61% | 184.00% |
| Total Finance Division Other Current Liabilities | -- | -99.98% | 16.18% | 349.55% | 1,491,900.00% |
| Total Other Current Liabilities | -- | -99.98% | 16.18% | 349.55% | 1,491,900.00% |
| Total Current Liabilities | -8.85% | -49.84% | 28.09% | 54.88% | 81.45% |
|
|
|||||
| Total Current Liabilities | -8.85% | -49.84% | 28.09% | 54.88% | 81.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -34.16% | 1.58% | 78.74% | 75.75% | 105.99% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.85% | -49.84% | 28.09% | 54.88% | 81.45% |
|
|
|||||
| Common Stock & APIC | 1.24% | 5.23% | 4.08% | 1.90% | 0.74% |
| Retained Earnings | -1.55% | -2.80% | -5.12% | -4.98% | -3.21% |
| Treasury Stock & Other | -92.22% | 12.53% | -18.71% | -30.37% | -27.63% |
| Total Common Equity | -19.97% | 129.87% | -34.34% | -50.07% | -29.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.97% | 129.87% | -34.34% | -50.07% | -29.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -59.08% | 33.28% | -42.64% | -15.69% | -10.17% |
| Total Equity | -32.03% | 266.72% | -54.80% | -56.62% | -31.97% |
|
|
|||||